Welcome to the ValueWiki IMUGENE LIMITED (IMU.AX) article! Register for free or click the "edit" link to contribute!
IMUGENE LIMITED (IMU.AX)
From ValueWiki
Business Description from asx.com.au: An Australian biopharmaceutical company specialising in the development and commercialisation of animal health products for production and companion (pet) animals.[1]
You can add information to this page! Just click any blue [ edit ] link to contribute.
|
|
[edit]
Company Analysis
You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.
The edit window has shortcut and help links if you need them.[2] Be bold!
[edit]
News Feed
[edit]
Leadership
- IMUGENE LIMITED Executive Information
- IMUGENE LIMITED Directors / Senior Management[1]
Mr Graham Dowland (Managing Director, Executive Chairman) Dr Warwick Lamb (Executive Director) Mr Roger Steinepreis (Non Exec. Director) Mr Paul MacLeman (Chief Op. Officer)
[edit]
Risks
This section needs content! Click the blue edit link (to the right) to contribute.
[edit]
Research Links
- IMUGENE LIMITED Profile
- IMUGENE LIMITED Fundamentals
- IMUGENE LIMITED Technical Analysis
- IMUGENE LIMITED Contact Information[1]
- Website: http://www.imugene.com
- Address: Level 1 , 14-20 Delhi Road , NORTH RYDE , NSW, AUSTRALIA, 2113
- Phone: 02 9870 7330
- Fax: 02 9888 9338
- Share Registry: COMPUTERSHARE INVESTOR SERVICES PTY LIMITED LEVEL 2, RESERVE BANK BUILDING , 45 ST GEORGE'S TERRACE , PERTH , WA, AUSTRALIA, 6000
- Share Registry Phone: 1300 787 575 (BKR ONLY)
- IMUGENE LIMITED Message Boards
[edit]
Notes
- ↑ 1.0 1.1 1.2 http://www.asx.com.au/asx/research/CompanyInfoSearchResults.jsp?searchBy=asxCode&allinfo=on&asxCode=IMU ASX.com.au
- ↑ This is a sample reference.
